Purines and myocardial protection
著者
書誌事項
Purines and myocardial protection
(Developments in cardiovascular medicine, v. 181)
Kluwer Academic Publishers, c1996
大学図書館所蔵 全10件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
A critical review of the most up-to-date research on purines and myocardial protection. The role of purines in reversible `myocardial stunning' and irreversible (myocardial infarction) ischemic injury, ventricular arrhythmias, and ischemic preconditioning is discussed in detail, by experts. All reviews address recent and rather controversial issues on purines and myocardial protection. Mechanisms of cardioprotection of exogenous versus endogenous purines are discussed in detail. The contribution of internationally recognized experts in the field of purines and cardiovascular physiology and in myocardial protection makes this a unique and interesting book for clinicians, basic scientists and students.
目次
- Part I: Purine Metabolism in the Heart 1. Physiologic and Pathophysiologic Significance of Purine Metabolism in the Heart
- A.-S.A. Abd-Elfattah, et al. 2. Purine Metabolism in the Ischemic Canine and Human Immature Myocardium Deficient of 5?-Nucleotidase
- A.- S.A. Abd-Elfattah, et al. 3. Cardiac Adenosine Metabolism: Physiological Implications
- A. Deusson. 4. Purines Metabolism in Human Cardiomyocytes and Endothelium-Implications for Protection of the Heart during Cardiac Surgery
- R.T. Smolenski, M. Yacoub. 5. Assessment of Interstitial Fluid Adenosine: Implications for Exogenous or Endogenous and Endogenous Adenosine-Mediated Cardioprotection
- D.G.L. Van Wylen. 6. Adenosine and Coronary Vascular Pharmacology
- W. Abebe, et al. 7. Alternations in Energy Substrate Metabolism during Oxidative Stress
- A.S. Clanachan, Gary Lopaschuck. Part II: Myocardial Protection with Purines. 8. Purines and Myocardial Protection: An Overview
- A.-S.A. Abd-Elfattah, et al. A. Myocardial Protection with Endogenous Purines. 9. Nucleoside Transport Protein: Properties and Regulation
- A.-S.A. Abd-Elfattah, et al. 10. Role of Nucleoside Transport in Myocardial Injury and Protection: Separation Between Ischemic and Reperfusion Injury using a Selective Nucleoside Transport Blocker, NBMPR
- A.-S.A. Abd-Elfattah, et al. 11. Myocardial Protection using Nucleoside Transport Inhibitors
- H. Van Belle. 12. Selective Blockade of Nucleoside Transport by NBMPR Attenuates Reperfusion-Mediated Ventricular Arrhythmias
- A.-S.A. Abd-Elfattah, et al. 13. NucleosideTransport in the Human Myocardium
- J. Hoehner, et al. 14. Selective Nucleoside Transport Blocker NBMPR Attenuates Myocardial Stunning in a Rabbit Mode- Deficient of Xanthine Oxidase
- A.-S.A. Abd-Elfattah, et al. 15. Amplification of Endogenous Adenosine by `Adenosine Regulating Agents' as a Therapeutic Approach to the Treatment of Cardiac Ischemic Syndromes
- K. Mullane, et al. B. Myocardial Protection with Exogenous Purines. 16. Organ Protection with ATP-Magnesium Chloride
- J.M. Harkema, I.H. Chaudry. 17. Adenosine and Adenosine Receptor Protection of the Ischemic Heart
- R.D. Lasely, R.J. Mentzer, Jr. 18. Effect of Adenosine on Myocardial Stunning
- M. Jerudi, et al. 19. Cardioprotection with Adenosine, inosine and Hypoxanthine
- J.W. de Jong, et al. 21. Adenosine and Adrenergic Mediated Effects in the Heart
- J.G. Dobson, Jr. 22. Effects of Adenosine on Ventricular Tachycardia
- A. Pelleg, J. Xu. 23. Purines and Ventricular Arrhythmias
- R. Fenton. 24. Adenosine and the Polymorphonuclear Leukocyte Function, Metabolism and Production
- B. Cornstein. 25. Purines and Regulation of Platelet Activation
- K. Agrwal. Part III: Purines and Myocardial Preconditioning. 26. Myocardial Preconditioning: From a Model to a Phenomenon
- A.-S. Abd-Elfattah, et al. 27. ATP Metabolism and Ischemic Preconditioning
- K.A. Reimer, et al. 28. Do Adenosine A3 Receptors Cause Preconditioning? J.M. Downey, et al. 29. KATP Channels and Adenosine Receptors and Ischemic
「Nielsen BookData」 より